Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1623 1673 1693
This examiner grants 73% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18560242 | COMBINATION THERAPIES | Non-Final OA | Janssen Pharmaceutica NV |
| 18258731 | PENETRATING CRYOPROTECTION AGENTS AND METHODS OF MAKING AND USING SAME | Non-Final OA | The Research Foundation for The State University of New York |
| 18321563 | Pet Food Compositions | Non-Final OA | Hill's Pet Nutrition, Inc. |
| 18739149 | NUCLEOTIDE HEMI-SULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS | Final Rejection | Atea Pharmaceuticals, Inc. |
| 18252394 | MODIFIED SOPHOROLIPID FOR IMPROVED BIOAVAILABILITY OF AMINO ACIDS AND METHOD OF USE | Final Rejection | LOCUS SOLUTIONS IPCO, LLC |
| 18495216 | NONWOVEN GLUCAN WEBS | Non-Final OA | NUTRITION & BIOSCIENCES USA 4, INC. |
| 18386643 | PURIFICATION METHOD FOR SUCRALOSE-6-ETHYL ESTER | Non-Final OA | ANHUI JINHE INDUSTRIAL CO., LTD. |
| 18483622 | BIOSYNTHETIC PRODUCTION OF STEVIOL GLYCOSIDES | Non-Final OA | Conagen Inc. |
| 18477929 | HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE | Non-Final OA | Teon Therapeutics, Inc. |
| 18477946 | HETEROCYCLIC INHIBITORS OF CD73 FOR TREATMENT OF DISEASE | Non-Final OA | Teon Therapeutics, Inc. |
| 18281211 | HEMOSTATIC MATERIAL | Non-Final OA | ARTISAN LAB CO., LTD. |
| 18279150 | GLUCOCEREBROSIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Non-Final OA | DONGGUAN HEC CORDYCEPS R&D CO., LTD. |
| 18022855 | PROCESS FOR THE DIRECT CONVERSION OF CELLULOSE TO GLYCOLS USING NON-NOBLE METAL LOADED ZEOLITE CATALYSTS | Non-Final OA | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy